Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 191.53 USD -1.02%
Market Cap: 338.8B USD
Have any thoughts about
Abbvie Inc?
Write Note

Wall Street
Price Targets

ABBV Price Targets Summary
Abbvie Inc

Wall Street analysts forecast ABBV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABBV is 217.95 USD with a low forecast of 174.73 USD and a high forecast of 263.55 USD.

Lowest
Price Target
174.73 USD
9% Downside
Average
Price Target
217.95 USD
14% Upside
Highest
Price Target
263.55 USD
38% Upside
Abbvie Inc Competitors:
Price Targets
PEB
Pacific Edge Ltd
32% Downside
CMRX
Chimerix Inc
2% Upside
IONS
Ionis Pharmaceuticals Inc
94% Upside
SOBI
Swedish Orphan Biovitrum AB (publ)
29% Upside
RNAC
Cartesian Therapeutics Inc
236% Upside
214450
PharmaResearch Co Ltd
8% Downside
SANA
Sana Biotechnology Inc
467% Upside
4599
StemRIM Inc
120% Upside

Revenue
Forecast

Revenue Estimate
Abbvie Inc

For the last 8 years the compound annual growth rate for Abbvie Inc's revenue is 10%. The projected CAGR for the next 3 years is 7%.

10%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Abbvie Inc

For the last 8 years the compound annual growth rate for Abbvie Inc's operating income is 7%. The projected CAGR for the next 3 years is 28%.

7%
Past Growth
28%
Estimated Growth
Estimates Accuracy
-31%
Average Miss

Net Income
Forecast

Net Income Estimate
Abbvie Inc

For the last 8 years the compound annual growth rate for Abbvie Inc's net income is -4%. The projected CAGR for the next 3 years is 87%.

-4%
Past Growth
87%
Estimated Growth
Estimates Accuracy
-53%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ABBV's stock price target?
Price Target
217.95 USD

According to Wall Street analysts, the average 1-year price target for ABBV is 217.95 USD with a low forecast of 174.73 USD and a high forecast of 263.55 USD.

What is Abbvie Inc's Revenue forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for Abbvie Inc's revenue is 10%. The projected CAGR for the next 3 years is 7%.

What is Abbvie Inc's Operating Income forecast?
Projected CAGR
28%

For the last 8 years the compound annual growth rate for Abbvie Inc's operating income is 7%. The projected CAGR for the next 3 years is 28%.

What is Abbvie Inc's Net Income forecast?
Projected CAGR
87%

For the last 8 years the compound annual growth rate for Abbvie Inc's net income is -4%. The projected CAGR for the next 3 years is 87%.

Back to Top